Article

Impact of the number of resected and involved lymph nodes on esophageal cancer survival

Journal of Surgical Oncology (Impact Factor: 2.84). 08/2009; 100(2):127 - 132. DOI: 10.1002/jso.21312

ABSTRACT Background
Using a large data set, we investigated the impact of the number of resected and involved lymph nodes on overall survival for patients with esophageal cancer.Methods
From the National Oncology Database™, esophageal cancer cases with data available on the total number of resected and involved nodes as well as other variables were evaluated as it relates to overall survival by multivariate analysis using Cox proportional hazards method. Patients with 0, exactly 1 or 1–3 positive nodes were separately studied to determine the association between the number of lymph nodes resected and overall survival.ResultsFrom 1969 to 2002, 3,144 (17%) of 18,390 esophageal cancer cases with complete data were identified. Increasing number of involved nodes predicted poorer outcome (P < 10−6). Results from studying patients with 0, exactly 1 or 1–3 positive nodes showed that survival improved with increasing number of nodes analyzed up to 12. Three-tier nodal grouping with increasing risk of death were identified, 0, 1–3, and ≥4 positive nodes (P < 10−5).Conclusions
The pathological assessment of minimal 12 lymph nodes provides sufficient prognostic information. Three-tier nodal grouping is suggested for the next version of AJCC staging system for esophageal cancer. J. Surg. Oncol. 2009;100:127–132. © 2009 Wiley-Liss, Inc.

0 Followers
 · 
66 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: An algorithm is described which operates on a digitized television frame or digital infrared image to rapidly locate tightly clustered objects which occupy less than half the field of view and which can be enclosed by rectangles. The algorithm uses a maximum entropy image and projections in place of arbitrary heuristics to guide the location and segmentation process.
    Acoustics, Speech, and Signal Processing, IEEE International Conference on ICASSP '84.; 04/1984
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patients with esophageal carcinoma who appear to have a complete response at the primary tumor site after undergoing neoadjuvant chemoradiotherapy may still have residual disease in regional lymph nodes despite clinically negative restaging (ypT0N1). We hypothesized that these patients would have similar survival to patients with incomplete response to therapy. We reviewed 336 esophageal cancer patients who received neoadjuvant chemoradiotherapy followed by complete resection. We identified 20 patients who obtained complete pathologic response at the primary tumor with persistent metastatic disease to regional lymph nodes (ypT0N1). These patients were compared to 123 patients with pathologic complete response and 193 with partial response for overall survival. Demographics among the three groups of patients were similar except that this cohort of patients with ypT0N1 had higher initial clinical stage (p = 0.013) and had more squamous cell carcinoma pathology (p = 0.005). Eighty-six percent of the ypT0N1 patients who had modern preoperative staging were felt to have clinical complete response. Five-year survival of ypT0N1 patients was intermediate, similar to pathologic partial response stage II patients in both the sixth and seventh editions of the American Joint Committee on Cancer staging criteria. Clinical staging of complete response to chemoradiotherapy may not translate to pathologic complete response. Patients with ypT0N1 disease at resection have intermediate but reasonable survival, justifying an aggressive approach to curative therapy. Future revisions of the staging system should place this group of patients with patients who have metastatic regional lymph nodes, stratified by number of nodes involved.
    The Annals of thoracic surgery 09/2010; 90(3):884-90; discussion 890-1. DOI:10.1016/j.athoracsur.2010.03.116 · 3.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lymphadenectomy is a standard component of esophagectomy, but how extensive it should be for accurate cancer staging and to maximize survival is controversial. In developing recommendations for extent of lymphadenectomy during esophagectomy, we will first review new knowledge about the anatomy of the esophageal lymphatics, both within the esophageal wall and the “region,” and its implications for regional lymph node metastases, which in turn affect survival. We will then review the literature to develop recommendations for extent of lymphadenectomy during esophagectomy. Finally, we will examine controversies surrounding the mechanisms by which lymphadenectomy influences survival following esophagectomy.
    12/2010: pages 223-231;